The company intends to use the funds raised in this round of financing to fully launch research and development and build a business foundation in the area of feline infectious peritonitis and other animal diseases for which effective treatment options are still limited.

Funding Summary
Round: Seed Round
Underwriters: Oita VC Success Fund No. 7 Investment Limited Partnership, Houwa Foundation and Business Succession Support Investment Limited Partnership
Use of Funds:
- Research and development of veterinary drugs
- Preparation for non-clinical and clinical trials
- Strengthen R&D structure and business foundation
Business Background
While pets have become more and more a part of the family in recent years, treatment options for serious diseases in veterinary medicine, especially cats, are still limited.
FIP has long been considered an "incurable disease" and has been a major challenge for owners and veterinarians. At present, there are no effective treatments or preventative drugs officially approved in Japan or abroad, and it is the third leading cause of death in cats.
In addition to the practical application of FECV antiviral drugs that target FECV in the intestines and eliminate it before it mutates into FIP, Happy Cat and Dog aims to create new treatment options based on scientific evidence by utilizing research findings from both human and veterinary medicine.
Features of Happy Kitty Dog
Drug discovery research infrastructure in collaboration with universities and research institutions
Applying research and development knowledge at the level of pharmaceuticals for humans to veterinary medicine
Team structure across research, clinical, and business development
Future Outlook
The funding will be used as an opportunity to accelerate research and development, strengthen ties with advanced operating companies and domestic and overseas veterinarians and researchers, and develop a foundation for global expansion.
We will continue to take on the challenge of realizing a society in which animals and their owners can live together longer and with peace of mind.
Comment from Mr. Shigeru Matsuoka, Representative Director
We are now ready to deliver solutions to animal diseases, for which treatment options have been limited, based on the results of research conducted at the university. We will steadily work on both R&D and business to provide new options to the field of veterinary medicine."
Happy Cat and Doggie|Company Profile
| name of company | Happy Cat and Doggie Co. |
| Establishment | November 2025 |
| Location | Oita Central Building 2F, 1-4-24, Chuo-cho, Oita City, Oita Prefecture |
| representative | Shigeru Matsuoka |
| Business Overview | Veterinary Therapeutics Development Business |
| how funds are used | Development funds for commercialization of FECV anthelmintics |









